Mojgan Gharipour1, Masoumeh Sadeghi2, Mohsen Hosseini3, Elham Andalib4, Maraym Bakhtiari Boroujeni5, Nizal Sarrafzadegan6. 1. Department of Metabolic Syndrome, Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences, Isfahan, Iran. 2. Department of Cardiology, Cardiac Rehabilitation Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran. 3. Department of Biostatistics, Skin Disease and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran. 4. Hypertension Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran. 5. Nutrition Research, Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran. 6. Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Abstract
BACKGROUND: This study aimed to determine how age groups effect on the phenotype of metabolic syndrome (MetS) among Iranian population. MATERIALS AND METHODS: This cross-sectional study was conducted as part of Isfahan Healthy Heart Program. Height, weight, waist circumference, and blood pressure were measured by trained health-care professionals. MetS was defined as having three or more of the National Cholesterol Education Program III criteria. The relation between different age groups and different phenotypes of MetS was examined using the multinomial logistic regression. RESULTS: We found low high-density lipoprotein-cholesterol (HDL-c) was the most common feature, followed by hypertriglyceridemia (HTG), abdominal obesity (ABO), hypertension (HTN), and high fasting blood glucose in decreasing order of prevalence. The most prevalent combination of MetS components was hypertrigeceridemia, low HDL-c and ABO (50.7%) in all subjects and especially in younger age group (63.2%). In elder age group, the most prevalent three components combination was HTG, Low HDL-c and HTN (43.9%). Logistic regression analysis demonstrated that elder subjects were at approximately 12 times higher risk of having the combination HTG, ABO, low HDL-c, and HTN (P < 0.001) compared to the middle age subjects who had a lower risk for the same combination; (2 [1.49-3.49]) (P < 0.001). CONCLUSION: This study provides a nationally representative estimate of the prevalence of different phenotypes of MetS across different age groups. Regarding different phenotypes of MetS in various age groups need to have important implications in the clinical management of these patients and the implementation of public health.
BACKGROUND: This study aimed to determine how age groups effect on the phenotype of metabolic syndrome (MetS) among Iranian population. MATERIALS AND METHODS: This cross-sectional study was conducted as part of Isfahan Healthy Heart Program. Height, weight, waist circumference, and blood pressure were measured by trained health-care professionals. MetS was defined as having three or more of the National Cholesterol Education Program III criteria. The relation between different age groups and different phenotypes of MetS was examined using the multinomial logistic regression. RESULTS: We found low high-density lipoprotein-cholesterol (HDL-c) was the most common feature, followed by hypertriglyceridemia (HTG), abdominal obesity (ABO), hypertension (HTN), and high fasting blood glucose in decreasing order of prevalence. The most prevalent combination of MetS components was hypertrigeceridemia, low HDL-c and ABO (50.7%) in all subjects and especially in younger age group (63.2%). In elder age group, the most prevalent three components combination was HTG, Low HDL-c and HTN (43.9%). Logistic regression analysis demonstrated that elder subjects were at approximately 12 times higher risk of having the combination HTG, ABO, low HDL-c, and HTN (P < 0.001) compared to the middle age subjects who had a lower risk for the same combination; (2 [1.49-3.49]) (P < 0.001). CONCLUSION: This study provides a nationally representative estimate of the prevalence of different phenotypes of MetS across different age groups. Regarding different phenotypes of MetS in various age groups need to have important implications in the clinical management of these patients and the implementation of public health.
Entities:
Keywords:
Age groups; Iran; metabolic cardiovascular syndrome; phenotype
The metabolic syndrome (MetS) is a clinical syndrome characterized by clustering cardiovascular risk factors. MetS increase the risk of cardiovascular events, diabetes mellitus, and the related mortality.[123] Previous studies demonstrated a high prevalence of MetS among both adolescents and adults in Iran as well as other countries.[4567891011] In Iran, the high prevalence of specific components of MetS such as diabetes, hypertriglyceridemia (HTG), hypertension (HTN), and abdominal obesity (ABO), shown to be increasing during recent years.[12] Previous studies that were locally conducted in Iran, had reported the prevalence of MetS and its components in different age groups and in different population.[13] However, it is unclear how age effects on phonotype of MetS among Iranian population. We believe finding a correlation between age distribution, different MetS components and their phenotypes may give policy and health-care decision makers some indications for better planning. Moreover, these findings will create a new view points for clinicians. The aim of this study is to demonstrate the effect of age on the phenotype of MetS in Iranian population.
MATERIALS AND METHODS
This cross-sectional study conducted as a part of Isfahan Healthy Heart Program (IHHP). The IHHP was a 6 year comprehensive integrated community base program for cardiovascular disease (CVD) prevention and control through reducing CVD risk factors and improving life- style to encourage healthy behaviors.[1415] Participants in this secondary analysis were 4644 individuals aged over 19 years in resident Isfahan, which participate in the final phase of IHHP in 2007. Finally, 982 subjects with MetS based on National Cholesterol Education Program (NCEP) were studied. All participants signed an informed written consent and the study was approved by Research Council of Isfahan Cardiovascular Research Institute. Height, weight, waist circumference, and the blood pressure were measured by trained health-care professionals. We measured waist circumference at the part of the trunk located midway between the lower costal margin (bottom of the lower rib) and the iliac crest (top of the pelvic bone) while the person was standing with feet about 25-30 cm apart.After 15 min rest, blood pressure was measured twice on the right arm and in the sitting position. The mean of the two recordings was reported as patient's blood pressure. Subjects who had three or more of the criteria defined by NCEP was diagnosed with MetS. The criteria of NCEP include: (1) central obesity as the waist circumference > 102 cm in men and > 88 cm in women; (2) fasting plasma triglycerides ≥ 150 mg/dl; (3) low high-density lipoprotein-cholesterol (HDL-c) <40 mg/dl in men and < 50 mg/dl in women; (4) systolic blood pressure ≥ 130 mm Hg and/or diastolic blood pressure 85 mm Hg and/or antihypertensive agents (5) hyperglycemia with fasting plasma glucose ≥ 100 mg/dl and/or hypoglycemic medications.[16]
Statistical analysis
Age-specific data were analyzed with descriptive statistics to determine the general and clinical characteristics of the study participants. The Chi-square test and the ANOVA test were used to examine significant differences according to age groups. To identify the relation between age groups and different components of MetS were examined using the multinomial logistic regression with adjustments for general characteristics of the study participants such as smoking; nutritional habit and the physical activity were performed by presenting odds ratios (ORs) and their 95% confidence intervals. Since, the prevalence of low HDL-c + HTN + high fasting blood sugar (FBS) and HTN + ABO + high FBS was very low among younger and middle age subject so OR of elder subjects compared with younger plus middle age. All statistical analyses were conducted using the SPSS 16.0.
RESULTS
The prevalence of the MetS among the adults was 21.1%. The prevalence of MetS increased with age from 8.3% in young adults (aged 18-34 years) 30.8% in middle age (35-64) and 48.6% in elderly adults (65 years and older) (results not shown in table). The prevalence of the components of MetS varied in our study. Low HDL was the most common feature, followed by HTG, ABO, HTN and high fasting blood glucose (FBG) in decreasing order of prevalence. The prevalence of each specific component of MetS differed between younger and older adults. Compared to older adults, young adults had a higher prevalence of low HDL-c and a lower prevalence of high FBG. In the middle age subjects the same pattern for a single component was observed regardless of age. Low HDL-c plus obesity (67.3%) and HTG plus ABO (59.9%) were more prevalent combinations among our subjects. Low HDL-c was very prevalent in all subjects with MetS [Table 1]. 76% of young individuals with MetS had both ABO and low HDL-c levels compared to 68.5% of middle age and 54.1% of elder adults with MetS (P = 0.001).
Table 1
MetS components in patients with MetS
MetS components in patients with MetSIn subjects with MetS, we observed HTN and ABO in 56.1% of older individuals compared to only15.5% of younger adults (P = 0.001) [Table 1]. When we looked into a combination of three components namely HTG, low HDL-c and ABO, we found the highest prevalence (50.7%) in all subjects and especially in younger age group (63.2%). Middle age and elder groups followed the younger age group with prevalence of 50.5% and 37.8%, respectively. The most prevalent three components combination among elder subjects was HTG plus low HDL-c and HTN (43.9%) [Table 1]. In elder subjects the risk of having the combination of high FBS, ABO and Hypertrigeliceridemia was approximately 13 times more compared to younger and middle age groups (12.84 [4.49-36.69]).Our results revealed a significant correlation between age and the risk of having major risk factors (P > 0.01) [Table 2].
Table 2
Adjusted odds ratio for age groups according to the various MetS phenotype
Adjusted odds ratio for age groups according to the various MetS phenotype
DISCUSSION
Our findings showed phenotype of MetS is significantly different among different age groups. Previous evaluations of the IHHP data revealed relatively high prevalence of the MetS, which correlated with increasing prevalence of its individual components.[17] Large body of published studies reported an increasing in management of individual components of MetS such as HTN, diabetes, and dyslipidemia.[18] However, generally, MetS prevalence increased over the past decades in Iranian population as other ethnics.[1920]Previously, age related presence of MetS described in US population.[21] In a previous study, Sarrafzadegan et al. showed the prevalence of MetS in subjects aged over 60 years was significantly higher than those under 60.[19] However, our study adds to previous findings the age-related phenotypes of MetS in a relatively larger population. In addition, to the best of our knowledge this is the first time that the relationship between age groups and different phenotypes of MetS has discussed. Similar to other studies, our results showed a higher prevalence of the MetS in elder subjects and a larger number of the components of the syndrome clustering in elderly patients compared with younger patients. The prevalence of MetS was almost 4 times higher in individuals of 65 years and older compared with younger participants. Furthermore, the number of MetS components and their cluster was found higher in those aged 65 and older. This could be justified by hormonal changes over time especially in women.[22] Another study reported that with time secretary function of pancreatic β cells vary this could affect the development of insulin resistance and increase prevalence of MetS.[23]In the present study, we found that the number of MetS components in subjects over 65 years is significantly higher than younger participants. Other study reported similar findings in participants over 50 years.A recent study, which carried out in US showed the most frequent feature in young adults with MetS was ABO and low HDL-c in contrast to the oldest age group, in whom the triad of ABO, HTN, and HTG was most frequent.[24] They claimed that ABO was a predominant factor in all age groups in the western population and did not demonstrate any significant changes in prevalence across the age groups evaluated. However, our findings illustrated low HDL-c is dominant risk factor in all age-groups and followed by HTG in younger and middle age subjects and HTN in elder persons. Although in younger and middle age groups of Iranian low HDL-c, HTG and ABO are the more prevalent (63.2% and 50.7% respectively). The highest prevalent of three components combination among elder subjects was HTG plus low HDL-c and HTN (43.9%). Although Sumner et al. showed that HTG, HTN, and hyperglycemia significantly increased in prevalence with increasing age. Similar to Seo et al. study,[25] we found lower prevalence of ABO among elderly. It is well-documented that body weight and height decrease and fat mass increase, trunk, and visceral adipose tissue redistribute across higher age.[2627]Two other studies argued that risk factor clustering depends on the interaction between environmental and genetic factors. The penetrance of a particular common genetic factor involved in the simultaneous expression of several risk factors should permit clearer observation of risk factor clustering in younger subjects. A longer exposure to environmental factors that may lead to the development of particular individual risk factors in older subjects (principally HTN, which increased with age more than any other risk factor) may modify the risk factor clustering observed in this group. On the other hand, risk factor treatment also more prevalent in the 55-74 group.[2829] Ramos et al. claimed that in younger subjects blood pressure was related to lipids, obesity, and glycaemia.[30] In addition, Poulter found that obesity, smoking, glucose intolerance, physical inactivity, and dyslipidemia often co-exist with HTN in both older and younger age groups in Italian population.[31] Whereas, Pasini et al. studied the clustering of different combinations of CVD risk factors including systolic and diastolic HTN, total cholesterol, and obesity among aged 40-59 years Italian population.[32]
Limitations
First of all, we made a cross-sectional evaluation and our results are subjective; therefore, to survival bias. Some of combinations of traits were present in a very low number so that the OR could not be calculated or resulted no significant. Secondly, It was important to evaluate for sex limitation effects, but we did not investigate the effect of sex on the phenotype of MetS, because we did not access to some biological factors as hormonal levels as we as sex-specific behavior and life-style factors.
CONCLUSION
This study provides a nationally representative estimate of the prevalence of MetS and its different phenotypes among different age groups. Low HDL-c is the most prevalent component among all study groups. ABO is more prevalent in young adults with the Mets while HTN and HTG are more prevalent in older adults. Therefore, regarding different phenotypes of MetS in various age groups, need to have important implications in the clinical management of these patients and the implementation of public health.
Authors: Aldi T Kraja; Ingrid B Borecki; Kari North; Weihong Tang; Richard H Myers; Paul N Hopkins; Donna Arnett; Jonathan Corbett; Avril Adelman; Michael A Province Journal: Nutr Metab (Lond) Date: 2006-12-05 Impact factor: 4.169